1 North Wealth Services’s VanEck Biotech ETF BBH Stock Holding History

1 North Wealth Services’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16K	Hold	79	–	–	0.01%	151
2026 Q1	$14.8K	Hold	79	–	–	0.01%	138
2025 Q4	$14.9K	Buy	79 +1	+1%	+$185	0.01%	141
2025 Q3	$13K	Hold	78	–	–	0.01%	138
2025 Q2	$12K	Hold	78	–	–	﹤0.01%	140
2025 Q1	$12.3K	Buy	+78	New	+$12.7K	0.01%	136
2019 Q4	$11K	Hold	76	–	–	0.01%	188
2019 Q3	$9K	Buy	+76	New	+$9.45K	0.01%	158
2019 Q1	$10K	Hold	76	–	–	0.01%	146
2018 Q4	$8K	Buy	+76	New	+$9.18K	0.01%	160

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

1 North Wealth Services's BBH Position: Q2 2026 in Review

1 North Wealth Services held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 79 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #151.

1 North Wealth Services first reported a position in BBH in Q4 2018 and has held it in 10 quarters since. 110 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

1 North Wealth Services held 79 shares of VanEck Biotech ETF worth $16K as of Q2 2026.
1 North Wealth Services left its VanEck Biotech ETF share count unchanged in Q2 2026.
VanEck Biotech ETF made up 0.01% of 1 North Wealth Services's portfolio in Q2 2026, its #151 holding.
1 North Wealth Services first reported a position in VanEck Biotech ETF in Q4 2018 and has held it in 10 quarters since.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on 1 North Wealth Services's 13F filing for Q2 2026, filed 3 Aug 2026.